All sites C00-96,D32-33,D42-43,D45-47,D76 202 86.9 4.3 3.4 0.7 4.8
Mouth, pharynx C00-14 2 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 0 100.0 - - - -
  Mouth, other C03-06 0 100.0 - - - -
  Salivary glands C07-08 - - - - - -
  Pharynx C01,C09-14 - - - - - -
Digestive organs C15-26 42 73.1 13.9 6.7 - 6.3
  Oesophagus C15 1 100.0 - - - -
  Stomach C16 4 94.7 - 5.3 - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 17 92.8 2.4 1.2 - 3.6
  Rectum, rectosigmoid C19-20 5 100.0 - - - -
  Anus C21 0 100.0 - - - -
  Liver C22 2 50.0 25.0 - - 25.0
  Gallbladder, bile ducts C23-24 4 44.4 22.2 22.2 - 11.1
  Pancreas C25 8 21.1 47.4 21.1 - 10.5
  Other digestive organs C26 1 16.7 50.0 - - 33.3
Respiratory organs C30-39 10 68.0 6.0 10.0 4.0 12.0
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 9 69.6 6.5 8.7 4.3 10.9
  Mediastinum, pleura C38 0 - - 50.0 - 50.0
Bone C40-41 - - - - - -
Melanoma of the skin C43 7 97.2 - - - 2.8
Skin, non-melanoma C44 9 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 1 100.0 - - - -
Breast C50 61 99.3 0.3 - - 0.3
Female genital organs C51-58 23 93.9 2.6 0.9 0.9 1.8
  Cervix uteri C53 3 94.1 - - - 5.9
  Corpus uteri C54 13 96.8 - 1.6 - 1.6
  Uterus, other C55,C58 - - - - - -
  Ovary C56 4 95.0 5.0 - - -
  Other female genital C51-52,C57 3 78.6 14.3 - 7.1 -
Urinary organs C64-68 8 85.7 - 4.8 - 9.5
  Kidney C64 6 82.1 - 3.6 - 14.3
  Bladder and urinary tract2 C65-68 3 92.9 - 7.1 - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 9 88.4 - 7.0 - 4.7
Thyroid gland C73 7 97.1 - - - 2.9
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 6 26.7 20.0 16.7 13.3 23.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 18 81.8 1.1 4.5 - 12.5
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 7 97.0 - - - 3.0
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 3 64.3 - 7.1 - 28.6
  Leukaemia C91-95 5 82.6 4.3 8.7 - 4.3
  Myelodysplastic syndromes D46 1 42.9 - 14.3 - 42.9
  Myeloproliferaitive neoplasms D45,D47 1 50.0 - - - 50.0
Not included above
  Carcinoma in situ of the breast D05 3 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 16 100.0 - - - -
  Borderline tumour of the ovary D39 2 100.0 - - - -
  Basal cell carcinoma of the skin 59 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.